<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00893698</url>
  </required_header>
  <id_info>
    <org_study_id>2008/17</org_study_id>
    <secondary_id>2008-A00516-49</secondary_id>
    <nct_id>NCT00893698</nct_id>
  </id_info>
  <brief_title>Bilateral Allotransplantation of Upper Limbs</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assistance Publique Hopitaux De Marseille</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assistance Publique Hopitaux De Marseille</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the study is to realize a bilateral transplantation of upper limbs. The first&#xD;
      objective is functional but there are aesthetic and psychologic imperatives too. This open&#xD;
      and descriptive study needs compatible donor and recipient. The sample should be realized&#xD;
      simultaneously and the transplantation should be made by two coordinated teams according to&#xD;
      this sequence : osteosynthesis, vascular anastomosis, sutures of tendons and nervous sutures.&#xD;
      An immunosuppressant treatment should be initialized from the beginning of the intervention&#xD;
      and continued for life. Rejections should be screened by regular clinical and histological&#xD;
      examinations.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>January 2009</start_date>
  <primary_completion_date type="Anticipated">January 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Functional rehabilitation of patients by bilateral allotransplantation of upper limbs, evaluated by measure of the function of the transplanted extremities</measure>
    <time_frame>6 years</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Aesthetic and psychologic</measure>
    <time_frame>6 years</time_frame>
  </secondary_outcome>
  <enrollment type="Anticipated">5</enrollment>
  <condition>Patients Private of Their Upper Limbs</condition>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>bilateral allotransplantation</intervention_name>
    <description>bilateral allotransplantation of upper limbs</description>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        Donor:&#xD;
&#xD;
          -  State of brain death&#xD;
&#xD;
          -  Compatibility with recipient about sex, size, age and color&#xD;
&#xD;
          -  Blood compatibility; integrity of upper limbs&#xD;
&#xD;
        Recipient:&#xD;
&#xD;
          -  Double amputation of hands or forearms with traumatic origin&#xD;
&#xD;
          -  Personal motivation&#xD;
&#xD;
          -  Good health condition&#xD;
&#xD;
          -  Delay from 2 months to 34 years between amputation and transplantation&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        Donor:&#xD;
&#xD;
          -  Uncompatibility with sample&#xD;
&#xD;
          -  Lesion on upper limbs&#xD;
&#xD;
          -  Neoplasia&#xD;
&#xD;
          -  Hepatitis B or C&#xD;
&#xD;
          -  Positive CMV serology&#xD;
&#xD;
        Recipient:&#xD;
&#xD;
          -  Uncompatibility with immunosuppressant treatment&#xD;
&#xD;
          -  Psychosis&#xD;
&#xD;
          -  Carcinosis&#xD;
&#xD;
          -  Cardiovascular diseases&#xD;
&#xD;
          -  Addiction to alcohol or smoking&#xD;
&#xD;
          -  Pregnancy&#xD;
&#xD;
          -  Feeding&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Guy Magalon</last_name>
    <email>guy.magalon@ap-hm.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Assistance Publique Hopitaux de Marseille</name>
      <address>
        <city>Marseille</city>
        <zip>13354</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>guy MAGALON</last_name>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>August 2014</verification_date>
  <study_first_submitted>May 5, 2009</study_first_submitted>
  <study_first_submitted_qc>May 5, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 6, 2009</study_first_posted>
  <last_update_submitted>August 28, 2014</last_update_submitted>
  <last_update_submitted_qc>August 28, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 29, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

